Novartis has acquired global rights to develop, manufacture, and commercialize Leqvio under a licensing and collaboration agreement with Alnylam Pharmaceuticals, which is a leader in RNA...
The agreement between the two companies allows Debiopharm to access licensing options to continue the development of SunRock Biopharma's antibodies, integrating Debiopharm's innovative conjugation technologies, called...
The Viennese biotech company has developed a type of vaccine based on genetically modified arenaviruses. In the case of HB-200, these are vectors based on the...
The agreement signed between Microsoft and Ribera also involves collaboration with Futurs, the technological subsidiary of the Ribera Group, which thus becomes a partner of the...
The way stablecoins work is quite simple: for every stablecoin issued, the issuing company holds a corresponding equivalent value in secured assets. This means that if...
A little more than a week ago, the big IOTA upgrade Stardust took place. Since then, the price curve turned almost 9 percent into a minus....
On average, daily trading in XRP on global crypto exchanges records more than $500 million in turnover, and $1 billion on peak days. Whales have this...
The wearables developed by Onalabs, which are worn on the skin, act as micro-laboratories and aim to translate the language of biochemistry into useful data for...
Ledger says it has more than 700 employees, so about 80 employees are likely to have to go. Gauthier promises to comply with strict French labor...
Both projects started on April 1st, 2023, and are expected to last approximately two years. The biopharmaceutical company reduced its losses by 56% in the first...